BRIEF

on VALBIOTIS (EPA:ALVAL)

Half-year review of Valbiotis' liquidity contract

Stock price chart of VALBIOTIS (EPA:ALVAL) showing fluctuations.

Valbiotis, a French laboratory specializing in food supplements, has published the half-year report on its liquidity contract, prepared by Portzamparc. As of June 30, 2026, the liquidity account's assets comprised 45,947 Valbiotis shares and €22,631.28. Compared to December 31, 2025, the assets increased by 5,053 shares but decreased by €2,134.35.

During the first half of 2026, the total transaction volume reached 180,421 shares purchased for €177,122.59, while 175,368 shares were sold, generating €174,988.24. Purchase transactions totaled 528 compared to 492 sales.

R. H.

Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all VALBIOTIS news